Antiviral Therapy and the Development of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB) Patients with and without Cirrhosis in a US Population

被引：0
|
作者：
Lin, Derek [1 ]
Nguyen, Nghia H. [2 ]
Hoang, Joseph [3 ]
Vu, Vinh D. [3 ]
Trinh, Huy N. [4 ]
Li, Jiayi [5 ]
Zhang, Jian Q. [6 ]
Nguyen, Huy A. [4 ]
Khanh Nguyen [4 ]
Nguyen, Mindie H. [3 ]
机构：
[1] Stanford Univ Med Ctr, Palo Alto, CA USA
[2] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[3] Stanford Univ Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA USA
[4] San Jose Gastroenterol, San Jose, CA USA
[5] Palo Alto Med Fdn, Palo Alto, CA USA
[6] Chinese Hosp, San Francisco, CA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1641
引用
收藏
页码：988A / 988A
页数：1
相关论文
共 50 条
  • [41] EXCELLENT 5-YEAR SURVIVAL IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS WITH OR WITHOUT CIRRHOSIS UNDER LONG-TERM ENTECAVIR (ETV) OR TENOFOVIR (TDF) THERAPY AND THE IMPACT OF HEPATOCELLULAR CARCINOMA (HCC)
    Papatheodoridis, G.
    Dalekos, G.
    Yurdaydin, C.
    Buti, M.
    Sypsa, V.
    Goulis, J.
    Calleja, J. L.
    Chi, H.
    Manolakopoulos, S.
    Mangia, G.
    Gatselis, N.
    Keskin, O.
    Savvidou, S.
    De La Revilla, J.
    Hansen, B. E.
    Vlachogiannakos, I.
    Galanis, K.
    Idilman, R.
    Colombo, M.
    Esteban, R.
    Janssen, H. L.
    Lampertico, P.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S559 - S560
  • [42] The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
    Varbobitis, Ioannis
    Papatheodoridis, George V.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 319 - 326
  • [43] Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
    Lee, Minjong
    Chung, Goh Eun
    Lee, Jeong-Hoon
    Oh, Sohee
    Nam, Joon Yeul
    Chang, Young
    Cho, Hyeki
    Ahn, Hongkeun
    Cho, Young Youn
    Yoo, Jeong-ju
    Cho, Yuri
    Lee, Dong Hyeon
    Cho, Eun Ju
    Yu, Su Jong
    Lee, Dong Ho
    Lee, Jeong Min
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2017, 66 (05) : 1556 - 1569
  • [44] Effect of Antiviral Therapy and REACH-B Risk Score on Hepatocellular Carcinoma (HCC) Incidence in Chronic Hepatitis B (CHB) Patients Who Did Not Meet Treatment Criteria by AASLD, US Panel, EASL, or APASL Guideline
    Nguyen, Nghia H.
    Vu, Vinh D.
    Lin, Derek
    Hoang, Joseph K.
    Le, An K.
    Chaung, Kevin T.
    Nguyen, Vincent G.
    Trinh, Huy N.
    Li, Jiayi
    Zhang, Jian Q.
    Nguyen, Mindie H.
    HEPATOLOGY, 2015, 62 : 396A - 397A
  • [45] Hepatitis B therapy and incidence of hepatocellular carcinoma in a US population
    Gordon, Stuart C.
    Lamerato, Lois
    Rupp, Loralee B.
    Holmberg, Scott D.
    Moorman, Anne C.
    Spradling, Philip R.
    Teshale, Eyasu H.
    Nakasato, Cynthia
    Boscarino, Joseph A.
    Henkle, Emily
    Nerenz, David R.
    Oja-Tebbe, Nancy
    Lu, Mei
    HEPATOLOGY, 2012, 56 : 347A - 348A
  • [46] Decreasing risk of hepatocellular carcinoma (HCC) development after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
    Papatheodoridis, George V.
    Idilman, Ramazan
    Dalekos, George N.
    Buti, Maria
    Chi, Heng
    van Boemmel, Florian
    Luis Calleja, Jose
    Sypsa, Vana
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Invernizzi, Federica
    Siakavellas, Spyros I.
    Keskin, Onur
    Gatselis, Nikolaos
    Hansen, Bettina E.
    Lehretz, Maria
    de la Revilla, Juan
    Savvidou, Savvoula
    Kourikou, Anastasia
    Facchetti, Floriana
    Vlachogiannakos, Jiannis
    Galanis, Kostas
    Yurdaydin, Cihan
    Berg, Thomas
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    HEPATOLOGY, 2015, 62 : 1188A - 1189A
  • [47] Patterns of hepatitis B viral load level (HBV DNA), hepatitis B e antigen (HBeAg) status and risk factors of cirrhosis and hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients in Thailand
    Leuangarun, S.
    Sriprayoon, T.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E94 - E94
  • [48] Clinical Presentation of Chronic Hepatitis B (CHB) and C (CHC) and the Risks for Cirrhosis and/or Hepatic Decompensation (HD) and Hepatocellular Carcinoma (HCC) in Asian Americans
    Abbasi, Ali
    Pan, Calvin
    Xia, Victor W.
    Hu, Ke-Qin
    GASTROENTEROLOGY, 2010, 138 (05) : S840 - S840
  • [49] PAGE-B: RISK SCORE FOR HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS RECEIVING ENTECAVIR (ETV) OR TENOFOVIR (TDF)
    Papatheodoridis, G. V.
    Dalekos, G.
    Sypsa, V.
    Yurdaydin, C.
    Buti, M.
    Goulis, J.
    Arends, P.
    Manolakopoulos, S.
    Mangia, G.
    Gatselis, N.
    Keskin, O.
    Savvidou, S.
    Hansen, B. E.
    Papaioannou, C.
    Galanis, K.
    Idilman, R.
    Colombo, M.
    Esteban, R.
    Janssen, H. L. A.
    Lampertico, P.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S435 - S435
  • [50] Annual Incidence for Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Patients With Chronic Hepatitis B (CHB) and Cirrhotic Patients of All Etiologies
    Do, Ailinh L.
    Wong, Carrie R.
    Nguyen, Vincent G.
    Garcia, Ruel T.
    Trinh, Huy N.
    Kin, Kevin
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Levitt, Brian S.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2011, 140 (05) : S920 - S920
12345